Lesion Size Measurement During Gastrointestinal Endoscopies
Observational · No treatment assigned · 1 site · Centre hospitalier de l'Université de Montréal (CHUM)
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Polyp of Colon and Crohn Disease. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- Adult patients (18 years and older)
- Patients undergoing gastrointestinal endoscopy procedures
There are also 4 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 3000 participants are expected to take part.
- Start date: 2025-05-09.
- Main results expected around 2027-05 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Canada.
Main thing being measured
- Validity of AccuMeasure when measuring ulcer size in patients with Crohn's disease or ulcerative colitis (During the endoscopy)
In the researchers’ words
The goal of this prospective observational study is to assess the accuracy and reliability of laser readings obtained through AccuMeasure, in comparison to other measurements performed by gastroenterologists. AccuMeasure is a novel technology, that has emerged as a promising tool for measuring polyps and lesions during colonoscopies.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Polyp of Colon; Crohn Disease |
| Lead sponsor | Centre hospitalier de l'Université de Montréal (CHUM) |
| Enrollment | 3000 (estimated) |
| Start date | 2025-05-09 |
| Primary completion (est.) | 2027-05 |
| First posted | 2026-08-18 |
| Last updated | 2026-08-18 |
| Official title | Lesion Size Measurement During Gastrointestinal Endoscopies |
| ClinicalTrials.gov ID | NCT07770425 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Adult patients (18 years and older) * Patients undergoing gastrointestinal endoscopy procedures Exclusion Criteria: * Minors: Patients under 18 years of age. * Patients who do not provide informed consent. * Patients undergoing endoscopy on an emergency basis (defined as urgent diagnostic or therapeutic endoscopy performed on the gastrointestinal (GI) tract to address potentially life-threatening conditions or severe symptoms that require immediate medical attention). * An American Society of Anesthesiologists (ASA) physical status classification greater than 3.
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier de l'Université de Montréal | Montreal, Quebec | Canada | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.